SummaryThe breast cancer susceptibility protein, BRCA2, is essential for recombinational DNA repair. BRCA2 delivers RAD51 to double-stranded DNA (dsDNA) breaks through interaction with eight conserved, ∼35 amino acid motifs, the BRC repeats. Here we show that the solitary BRC4 promotes assembly of RAD51 onto single-stranded DNA (ssDNA), but not dsDNA, to stimulate DNA strand exchange. BRC4 acts by blocking ATP hydrolysis and thereby maintaining the active ATP-bound form of the RAD51-ssDNA filament. Single-molecule visualization shows that BRC4 does not disassemble RAD51-dsDNA filaments but rather blocks nucleation of RAD51 onto dsDNA. Furthermore, this behavior is manifested by a domain of BRCA2 comprising all eight BRC repeats. These resul...
BRCA2 is a tumor suppressor that functions in homologous recombination, a key genomic integrity path...
Homologous recombination is essential for the preservation of genome stability, thereby preventing c...
The cytotoxic action of anticancer drugs can be potentiated by inhibiting DNA repair mechanisms. RAD...
SummaryThe breast cancer susceptibility protein, BRCA2, is essential for recombinational DNA repair....
Mutation of the breast cancer susceptibility gene, BRCA2, leads to breast and ovarian cancers. Mecha...
Mutation of the breast cancer susceptibility gene, BRCA2, leads to breast and ovarian cancers. Mecha...
Human BRCA2, a breast and ovarian cancer suppressor, binds to the DNA recombinase RAD51 through eigh...
The interaction between the breast cancer susceptibility protein BRCA2 and the RAD51 DNA recombinase...
BRCA2 is essential for DNA repair by homologous recombination via its interaction with RAD51, mediat...
AbstractThe breast cancer susceptibility protein BRCA2 is essential for recombinational DNA repair. ...
Individuals carrying BRCA2 mutations are predisposed to breast and ovarian cancers. Here, we show th...
The breast cancer susceptibility protein BRCA2 is essential for recombinational DNA repair. BRCA2 sp...
Individuals with BRCA2 mutations are predisposed to breast cancers owing to genome instability. To d...
BRCA2 is an important tumor suppressor and functions in homologous recombination, a key genomic inte...
In somatic cells, BRCA2 is needed for RAD51-mediated homologous recombination. The meiosis-specific ...
BRCA2 is a tumor suppressor that functions in homologous recombination, a key genomic integrity path...
Homologous recombination is essential for the preservation of genome stability, thereby preventing c...
The cytotoxic action of anticancer drugs can be potentiated by inhibiting DNA repair mechanisms. RAD...
SummaryThe breast cancer susceptibility protein, BRCA2, is essential for recombinational DNA repair....
Mutation of the breast cancer susceptibility gene, BRCA2, leads to breast and ovarian cancers. Mecha...
Mutation of the breast cancer susceptibility gene, BRCA2, leads to breast and ovarian cancers. Mecha...
Human BRCA2, a breast and ovarian cancer suppressor, binds to the DNA recombinase RAD51 through eigh...
The interaction between the breast cancer susceptibility protein BRCA2 and the RAD51 DNA recombinase...
BRCA2 is essential for DNA repair by homologous recombination via its interaction with RAD51, mediat...
AbstractThe breast cancer susceptibility protein BRCA2 is essential for recombinational DNA repair. ...
Individuals carrying BRCA2 mutations are predisposed to breast and ovarian cancers. Here, we show th...
The breast cancer susceptibility protein BRCA2 is essential for recombinational DNA repair. BRCA2 sp...
Individuals with BRCA2 mutations are predisposed to breast cancers owing to genome instability. To d...
BRCA2 is an important tumor suppressor and functions in homologous recombination, a key genomic inte...
In somatic cells, BRCA2 is needed for RAD51-mediated homologous recombination. The meiosis-specific ...
BRCA2 is a tumor suppressor that functions in homologous recombination, a key genomic integrity path...
Homologous recombination is essential for the preservation of genome stability, thereby preventing c...
The cytotoxic action of anticancer drugs can be potentiated by inhibiting DNA repair mechanisms. RAD...